Combination of Vitamin C and Lenvatinib potentiates antitumor effects in hepatocellular carcinoma cells in vitro

Lenvatinib has become a first-line drug in the treatment of advanced hepatocellular carcinoma (HCC). Investigating its use in combination with other agents is of great significance to improve the sensitivity and durable response of Lenvatinib in advanced HCC patients. Vitamin C (L-ascorbic acid, asc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyue, Qian, Songyi, Wang, Siyi, Jia, Sheng, Zheng, Nishang, Yao, Qing, Gao, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2023
Materias:
Biochemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884045/
https://www.ncbi.nlm.nih.gov/pubmed/36718449
http://dx.doi.org/10.7717/peerj.14610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884045/
https://www.ncbi.nlm.nih.gov/pubmed/36718449
http://dx.doi.org/10.7717/peerj.14610

Ejemplares similares